Immunohistochemistry of wild type and hjv-/- iron manipulated mouse livers and spleens treated with LPS or Hepcidin
Data files
Apr 14, 2023 version files 11.81 GB
-
808_FPN_HJVKO_IDD_CT_807_21LS.svs
167.64 MB
-
808_FPN_HJVKO_IDD_CT_807_22LS.svs
104.12 MB
-
808_FPN_HJVKO_IDD_CT_807_34LS.svs
107.21 MB
-
808_FPN_HJVKO_IDD_LPS_808_17LS.svs
86.20 MB
-
808_FPN_HJVKO_IDD_LPS_808_18LS.svs
109.40 MB
-
808_FPN_HJVKO_IDD_LPS_808_19LS.svs
115.76 MB
-
808_FPN_HJVKO_ND_CT_807_5LS.svs
102.31 MB
-
808_FPN_HJVKO_ND_CT_807_6LS.svs
99.73 MB
-
808_FPN_HJVKO_ND_CT_807_7LS.svs
121.77 MB
-
808_FPN_HJVKO_ND_LPS_808_10LS.svs
138.82 MB
-
808_FPN_HJVKO_ND_LPS_808_12LS.svs
117.13 MB
-
808_FPN_HJVKO_ND_LPS_808_9LS.svs
146.31 MB
-
808_FPN_WT_CID_CT_807_58LS.svs
149.57 MB
-
808_FPN_WT_CID_CT_807_60LS.svs
132.31 MB
-
808_FPN_WT_CID_CT_807_61LS.svs
112.15 MB
-
808_FPN_WT_CID_LPS_808_26LS.svs
123.36 MB
-
808_FPN_WT_CID_LPS_808_27LS.svs
86.13 MB
-
808_FPN_WT_CID_LPS_808_28LS.svs
143.66 MB
-
808_FPN_WT_ND_CT_807_3LS.svs
110.75 MB
-
808_FPN_WT_ND_CT_807_4LS.svs
87.02 MB
-
808_FPN_WT_ND_CT_808_1LS.svs
184.76 MB
-
808_FPN_WT_ND_LPS_808_24LS.svs
106.64 MB
-
808_FPN_WT_ND_LPS_808_25LS.svs
142.41 MB
-
808_FPN_WT_ND_LPS_808_32LS.svs
97.94 MB
-
808_Perls_HJVKO_IDD_CT_807_21LS.svs
166.04 MB
-
808_Perls_HJVKO_IDD_CT_807_22LS.svs
109.38 MB
-
808_Perls_HJVKO_IDD_CT_807_34LS.svs
109.57 MB
-
808_Perls_HJVKO_IDD_LPS_808_17LS.svs
91.66 MB
-
808_Perls_HJVKO_IDD_LPS_808_18LS.svs
112.22 MB
-
808_Perls_HJVKO_IDD_LPS_808_19LS.svs
123.39 MB
-
808_Perls_HJVKO_ND_CT_807_5LS.svs
105.44 MB
-
808_Perls_HJVKO_ND_CT_807_6LS.svs
118.37 MB
-
808_Perls_HJVKO_ND_CT_807_7LS.svs
123.84 MB
-
808_Perls_HJVKO_ND_LPS_808_10LS.svs
129.59 MB
-
808_Perls_HJVKO_ND_LPS_808_12LS.svs
118.01 MB
-
808_Perls_HJVKO_ND_LPS_808_9LS.svs
150.42 MB
-
808_Perls_WT_CID_CT_807_58LS.svs
148.82 MB
-
808_Perls_WT_CID_CT_807_60LS.svs
136.56 MB
-
808_Perls_WT_CID_CT_807_61LS.svs
116.35 MB
-
808_Perls_WT_CID_LPS_808_26LS.svs
120.84 MB
-
808_Perls_WT_CID_LPS_808_27LS.svs
85.62 MB
-
808_Perls_WT_CID_LPS_808_28LS.svs
141.22 MB
-
808_Perls_WT_ND_CT_807_3LS.svs
105.92 MB
-
808_Perls_WT_ND_CT_807_4LS.svs
92.91 MB
-
808_Perls_WT_ND_CT_808_1LS.svs
201.37 MB
-
808_Perls_WT_ND_LPS_808_24LS.svs
96.31 MB
-
808_Perls_WT_ND_LPS_808_25LS.svs
144.70 MB
-
808_Perls_WT_ND_LPS_808_32LS.svs
107.49 MB
-
809_FPN_HJV_IDD_Hep_809_31LS.svs
74.23 MB
-
809_FPN_HJV_IDD_Hep_809_32LS.svs
103.83 MB
-
809_FPN_HJV_IDD_Hep_809_35LS.svs
127.20 MB
-
809_FPN_HJV_IDD_PBS_809_27LS.svs
113.56 MB
-
809_FPN_HJV_IDD_PBS_809_28LS.svs
83.77 MB
-
809_FPN_HJV_IDD_PBS_809_29LS.svs
86.08 MB
-
809_FPN_HJV_ND_Hep_809_14LS.svs
169.20 MB
-
809_FPN_HJV_ND_Hep_809_5LS.svs
158.44 MB
-
809_FPN_HJV_ND_Hep_809_7LS.svs
122.84 MB
-
809_FPN_HJV_ND_PBS_809_10LS.svs
146.66 MB
-
809_FPN_HJV_ND_PBS_809_3LS.svs
106.61 MB
-
809_FPN_HJV_ND_PBS_809_9LS.svs
141.33 MB
-
809_FPN_WT_CID_Hep_809_46LS.svs
150.54 MB
-
809_FPN_WT_CID_Hep_809_47LS.svs
147.07 MB
-
809_FPN_WT_CID_Hep_809_49LS.svs
120.99 MB
-
809_FPN_WT_CID_PBS_809_39LS.svs
134.48 MB
-
809_FPN_WT_CID_PBS_809_40LS.svs
131.78 MB
-
809_FPN_WT_CID_PBS_809_41LS.svs
148.20 MB
-
809_FPN_WT_ND_Hep_809_19LS.svs
111.66 MB
-
809_FPN_WT_ND_Hep_809_20LS.svs
184.30 MB
-
809_FPN_WT_ND_Hep_809_21LS.svs
110.06 MB
-
809_FPN_WT_ND_PBS_809_17LS.svs
99.62 MB
-
809_FPN_WT_ND_PBS_809_51LS.svs
133.92 MB
-
809_FPN_WT_ND_PBS_809_52LS.svs
133.38 MB
-
809_Perls_HJV_IDD_Hep_809_31LS.svs
85.24 MB
-
809_Perls_HJV_IDD_Hep_809_32LS.svs
98.93 MB
-
809_Perls_HJV_IDD_Hep_809_35LS.svs
133.49 MB
-
809_Perls_HJV_IDD_PBS_809_28LS.svs
88.65 MB
-
809_Perls_HJV_IDD_PBS_809_29LS.svs
107.79 MB
-
809_Perls_HJV_ND_Hep_809_14LS.svs
174.29 MB
-
809_Perls_HJV_ND_Hep_809_5LS.svs
141.04 MB
-
809_Perls_HJV_ND_Hep_809_7LS.svs
127.13 MB
-
809_Perls_HJV_ND_PBS_809_10LS.svs
142.29 MB
-
809_Perls_HJV_ND_PBS_809_3LS.svs
105.37 MB
-
809_Perls_HJV_ND_PBS_809_9LS.svs
139.82 MB
-
809_Perls_WT_CID_Hep_809_46LS.svs
137.28 MB
-
809_Perls_WT_CID_Hep_809_47LS.svs
146.64 MB
-
809_Perls_WT_CID_Hep_809_49LS.svs
119.94 MB
-
809_Perls_WT_CID_PBS_809_39LS.svs
116.14 MB
-
809_Perls_WT_CID_PBS_809_40LS.svs
126.98 MB
-
809_Perls_WT_CID_PBS_809_41LS.svs
152.81 MB
-
809_Perls_WT_ND_Hep_809_19LS.svs
105.65 MB
-
809_Perls_WT_ND_Hep_809_20LS.svs
185.16 MB
-
809_Perls_WT_ND_Hep_809_21LS.svs
102.44 MB
-
809_Perls_WT_ND_PBS_809_17LS.svs
106.55 MB
-
809_Perls_WT_ND_PBS_809_51LS.svs
141.54 MB
-
809_Perls_WT_ND_PBS_809_52LS.svs
133.81 MB
-
README.csv
592 B
Abstract
The iron hormone hepcidin is transcriptionally activated by iron or inflammation via distinct, partially overlapping pathways. We addressed how iron affects inflammatory hepcidin levels and the ensuing hypoferremic response. Dietary iron overload did not mitigate hepcidin induction in LPS-treated wt mice but prevented effective inflammatory hypoferremia. Likewise, LPS modestly decreased serum iron in hepcidin-deficient Hjv-/- mice, model of hemochromatosis. Synthetic hepcidin triggered hypoferremia in control but not iron-loaded wt animals. Furthermore, it dramatically decreased hepatic and splenic ferroportin in Hjv-/- mice on standard or iron-deficient diet, but only triggered hypoferremia in the latter. Mechanistically, iron antagonized hepcidin responsiveness by inactivating IRPs in the liver and spleen, to stimulate ferroportin mRNA translation. Prolonged LPS treatment eliminating ferroportin mRNA permitted hepcidin-mediated hypoferremia in iron-loaded mice. Thus, de novo ferroportin synthesis is critical determinant of serum iron and finetunes hepcidin-dependent functional outcomes. Our data uncover a crosstalk between hepcidin and IRE/IRP systems that controls tissue ferroportin expression and determines serum iron levels. Moreover, they suggest that hepcidin supplementation therapy is more efficient combined with iron depletion.
Tissue specimens were fixed in 10% buffered formalin and embedded in paraffin. Samples from 3 different mice for each experimental condition were cut at 4-µm, placed on SuperFrost/Plus slides (Fisher) and dried overnight at 37°C. The slides were then loaded onto the Discovery XT Autostainer (Ventana Medical System) for automated immunohistochemistry. Slides underwent de-paraffinization and heat-induced epitope retrieval. Immunostaining was performed by using 1:500 diluted rabbit polyclonal antibodies against ferroportin and an appropriate detection kit (Omnimap rabbit polyclonal HRP, #760-4311 and ChromoMap-DAB #760-159; Roche). Negative controls were performed by the omission of the primary antibody. Slides were counterstained with hematoxylin for four minutes, blued with Bluing Reagent for four minutes, removed from the autostainer, washed in warm soapy water, dehydrated through graded alcohols, cleared in xylene, and mounted with Permount (Fisher). Sections were analyzed by conventional light microscopy and quantified by using the Aperio ImageScope software (Leica Biosystems).
Aperio ImageScope